Intellectual Property

Recce Pharmaceuticals currently has four wholly owned patent families, which include over 40 patents or patent applications and are constantly expanding, broadening, and developing the intellectual property portfolio.

Recce is committed to protecting its intellectual property estate of patent rights and trade secrets as well as the potential commercial and/or clinical advantages this protection provides for its proprietary technology.
Recce’s patent portfolio includes issued patents and patent applications in the world’s major markets, including the United States, Europe, Japan, China and Australia.

Patent Families

Protecting Recce’s unique and highly economical manufacturing process.
Filed Expiry Status

Australia

2028 Granted

USA

2029 Granted

Europe

2028 Granted

Germany

2028 Granted

Spain

2028 Granted

France

2029 Granted

UK

2028 Granted

Italy

2028 Granted

Sweden

2028 Granted

Japan

2028 Granted

China

2028 Granted
Protecting Recce’s drug delivery opportunities.
Filed Expiry Status

Australia

2035 Granted

USA

2035 Granted

Europe

2035 Granted

Germany

2035 Granted

Spain

2035 Granted

France

2035 Granted

UK

2035 Granted

Italy

2035 Granted

Sweden

2035 Granted

Japan

2035 Granted

China

2035 Granted
Anti-virus agent and method for treatment of viral infection.
Filed Expiry Status

Australia

2037 Granted

USA

2037 Granted

Europe

2037 Granted

Germany

2037 Granted

Spain

2037 Granted

France

2037 Granted

UK

2037 Granted

Italy

2037 Granted

Sweden

2037 Granted

Japan

2037 Granted

China

2037 Granted

Hong Kong

2037 Granted

Process for Preparation of Biologically Active Copolymer.

FiledExpiryStatus

Australia

2041Granted

Israel

2041Granted

Canada

2041Granted
Protecting RECCE® for use on antibiotic and pharmaceutical products and services
Filed Expiry Status

Australia

2026 Registered

USA

2026 Registered

Europe

2026 Registered

Japan

2026 Registered

China

2026 Registered

Hong Kong

2032 Registered

Vietnam

2033 Registered

Canada

2034 Registered